N
Novavax, Inc.
NVAX · NASDAQ · Healthcare · 1.3B
Price · close
$8.94
+6.18% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
3.3×
Price / net assetsP/B
—
Enterprise value / EBITDAEV/EBITDA
3.0×
Free cash flow yieldFCF yield
-17.3%
Return on equityROE
-344.7%
Operating margin
50.1%
Net debt / EBITDAbalance-sheet strength
0.0×
Interest coverage
25.0×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.